Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'group screening' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 19 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lewis, SM; Dean, AM
      Detection of interactions in experiments on large numbers of factors

      JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY
    2. Campone, M; Fumoleau, P; Delecroix, V; Deporte-Fety, R; Perrocheau, G; Vernillet, L; Borg-Olivier, O; Louboutin, JP; Bissery, MC; Riva, A; Azli, N
      Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer

      ANNALS OF ONCOLOGY
    3. Jassem, J; Pienkowski, T; Pluzanska, A; Jelic, S; Gorbunova, V; Mrsic-Krmpotic, Z; Berzins, J; Nagykalnai, T; Wigler, N; Renard, J; Munier, S; Weil, C
      Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: Final results of a randomized phase III multicenter trial

      JOURNAL OF CLINICAL ONCOLOGY
    4. Schmidinger, M; Budinsky, AC; Wenzel, C; Locker, GJ; Pluschnig, U; Brodowicz, T; Kubista, E; Maca, S; Zabernigg, A; Ilsinger, P; Seewann, L; Hojas, S; Blach, M; Zielinski, CC; Steger, GG
      Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    5. Burstein, HJ; Bunnell, CA; Winer, EP
      New cytotoxic agents and schedules for advanced breast cancer

      SEMINARS IN ONCOLOGY
    6. Lin, YC; Chang, HK; Wang, CH; Chen, JS; Liaw, CC
      Single-agent docetaxel in metastatic breast cancer patients pre-treated with anthracyclines and paclitaxel: partial cross-resistance between paclitaxel and docetaxel

      ANTI-CANCER DRUGS
    7. Burstein, HJ; Manola, J; Younger, J; Parker, LM; Bunnell, CA; Scheib, R; Matulonis, UA; Garber, JE; Clarke, KD; Shulman, LN; Winer, EP
      Docetaxel administered on a weekly basis for metastatic breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    8. Ferraresi, V; Milella, M; Vaccaro, A; D'Ottavio, AM; Papaldo, P; Nistico, C; Thorel, MF; Marsella, A; Carpino, A; Giannarelli, D; Terzoli, E; Cognetti, F
      Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients - A phase II study

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    9. Figgitt, DP; Wiseman, LR
      Docetaxel - An update of its use in advanced breast cancer

      DRUGS
    10. Bonneterre, J; Spielman, M; Guastalla, JP; Marty, M; Viens, P; Chollet, P; Roche, H; Fumoleau, P; Mauriac, L; Bourgeois, H; Namer, M; Bergerat, JP; Misset, JL; Trandafir, L; Mahjoubi, M
      Efficacy and safety of docetaxel (Taxotere (TM)) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience

      EUROPEAN JOURNAL OF CANCER
    11. Trudeau, ME
      Phase I-II studies of docetaxel as a single agent in the treatment of metastatic breast cancer

      SEMINARS IN ONCOLOGY
    12. Crown, J
      A review of the efficacy and safety of docetaxel as monotherapy in metastatic breast cancer

      SEMINARS IN ONCOLOGY
    13. Brown, RE; Hutton, J
      Cost-utility model comparing docetaxel and paclitaxel in advanced breast cancer patients

      ANTI-CANCER DRUGS
    14. Crown, J
      Evolution in the treatment of advanced breast cancer

      SEMINARS IN ONCOLOGY
    15. Dieras, V
      Taxanes in combination with doxorubicin in the treatment of metastatic breast cancer

      SEMINARS IN ONCOLOGY
    16. CURNOW RN; MORRIS AP
      POOLING DNA IN THE IDENTIFICATION OF PARENTS

      Heredity
    17. LANCASTER VA; KELLERMCNULTY S
      A REVIEW OF COMPOSITE SAMPLING METHODS

      Journal of the American Statistical Association
    18. VALERO V
      DOCETAXEL AS SINGLE-AGENT THERAPY IN METASTATIC BREAST-CANCER - CLINICAL EFFICACY

      Seminars in oncology
    19. DANDREA GM; SEIDMAN AD
      DOCETAXEL AND PACLITAXEL IN BREAST-CANCER THERAPY - PRESENT STATUS AND FUTURE-PROSPECTS

      Seminars in oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 02:13:05